CEO Matthew Doctor resigns effective June 30; Jim Lain interim CEO; Q4 SSS Supercuts +3.0%, consol +1.3%

REGIS CORP

CEO Matthew Doctor resigns effective June 30, 2025; remains part-time through Aug 31 at 50% base salary.
Board appoints Jim Lain as Interim CEO effective July 1; base salary $550k, target incentive 100% of base, plus $100k interim bonus.
Board forms Succession Planning Committee and engages search firm for permanent CEO; internal & external candidates considered.
Preliminary Q4 SSS: Supercuts +3.0%, Regis consolidated +1.3% for first two months; expenses inline with Q3.

item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Matthew Doctor

President and Chief Executive Officer

RGS · REGIS CORP

Effective: 2025-06-30
Successor: Jim Lain
Filed: Jun 23, 2025 23:59 UTC

On June 20, 2025, Matthew Doctor, the President and Chief Executive Officer and a member of the Board of Directors (the “Board”) of Regis Corporation (the “Company”) notified the Board that he would resign his positions, effective June 30, 2025.

Appointed (interim)

Jim Lain

Interim President and Chief Executive Officer

RGS · REGIS CORP

Effective: 2025-07-01
Filed: Jun 23, 2025 23:59 UTC

the Board appointed Jim Lain, the Company’s Executive Vice President, Brand Operations - Supercuts and Cost Cutters, to serve as Interim President and Chief Executive Officer, effective July 1, 2025

Source: SEC EDGAR

accession 0001193125-25-144132

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.